Skip to main content
Login
Contact
Subscribe
Search form
Search
Malvern Daily Record
Click for weather forecast
Home
Forms
Delivery Concerns
News
Sports
University of Arkansas
Classifieds
Place an Ad
Classified Display Ads
Service Directory
Obituaries
Entertainment
Special Sections
Talking About...
Photos
Videos
Games
Local Guide
Local Ads
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Roche Holding AG Basel American Depositary Shares
(OP:
RHHBY
)
43.61
USD
-0.27 (-0.63%)
Official Closing Price
/ Updated:
4:41 PM EDT, Jul 7, 2020
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
630,900
Open
43.63
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
43.88
Today's Range
43.59 - 43.96
52wk Range
25.10 - 46.00
Shares Outstanding
6,830,797,784
Dividend Yield
2.11%
Performance
YTD
+6.65%
+6.65%
1 Month
+1.73%
+1.73%
3 Month
+8.97%
+8.97%
6 Month
+7.15%
+7.15%
1 Year
+25.68%
+25.68%
Top News
More News
Cancer Immunotherapy Gets Boost from Newly Engineered Nanoparticles
June 25, 2020
category
Featured News
from
FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Cancer Immunotherapy Gets Boost from Newly Engineered Nanoparticles
June 25, 2020
FN Media Group Presents USA News Group News Commentary
Read More
from
PR Newswire
More News
Read More
Roche receives FDA approval for cobas EZH2 Mutation Test as a companion diagnostic for patients with follicular lymphoma
June 19, 2020
from
PR Newswire
FDA Approves Genentech’s Phesgo (Fixed-dose Combination of Perjeta and Herceptin for Subcutaneous Injection) for HER2-positive Breast Cancer
June 29, 2020
from
Business Wire News Releases
Genentech’s IPATential150 Study Evaluating Ipatasertib in Combination With Abiraterone and Prednisone/Prednisolone Met One of Its Co-Primary Endpoints
June 19, 2020
from
Business Wire News Releases
Genentech’s Tecentriq in Combination With Chemotherapy (including Abraxane) Meets Primary Endpoint of Improved Pathological Complete Response, Regardless of PD-L1 Status, as Initial Treatment for Peop
June 18, 2020
from
Business Wire News Releases
SpeeDx and Roche Partner to Expand Access to Antibiotic Resistance Tests
June 16, 2020
from
Business Wire News Releases
How gene therapy and CRISPR are helping to cure blindness
June 25, 2020
category
Medical Products
,
ABBV
,
Pharmaceuticals
, and 9 more.
from
MarketWatch
Positive Phase III Results for Venclexta Combination in Acute Myeloid Leukemia Presented At EHA 2020
June 13, 2020
from
Business Wire News Releases
Genentech Announces 2-Year Risdiplam Data From SUNFISH and New Data From JEWELFISH in Infants, Children and Adults With Spinal Muscular Atrophy (SMA)
June 12, 2020
from
Business Wire News Releases
Gilead Unveils New Wave Of Coronavirus Tests, Including Inhaled Drug
June 22, 2020
from
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
